Michael Hochman, MD, MPH, board certified general internist at USC’s Keck School of Medicine, cofounder of Updates in Slow Medicine, and host of the Healthy Skeptic, MD podcast,…
Pharmacomechanical thrombolysis can be particularly effective in mitigating post-thrombotic syndrome (PTS) in younger patients, as demonstrated by data from the ATTRACT trial.
Adam Schlifke, MD, MBA, practicing anesthesiologist and Clinical Assistant Professor of Anesthesiology, Perioperative and Pain Medicine at Stanford Medicine, has started a company with a unique model that will…
Adam Schlifke, MD, MBA, practicing anesthesiologist and Clinical Assistant Professor of Anesthesiology, Perioperative and Pain Medicine at Stanford Medicine, has created a process for quickly and effectively converting the…
The proportion of risk for alcohol use disorder (AUD) that can be attributed to genetic factors is as high as 60%. This data invokes heritability comparisons to both…
Alcohol use disorder (AUD) is notoriously difficult to treat, but a new therapeutic option may be on the horizon. Ondansetron, a competitive serotonin type 3 receptor antagonist currently…
Alcohol is the world’s seventh-leading cause of disease burden, researchers found, and is the top risk factor for a variety of diseases in people ages 15-49. Over time,…
